NovaBay Pharmaceuticals To Present At Southern California Investor Conference

By July 3, 2013

NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY), a clinical-stage biotechnology company focused on the topical, anti-infective market, today announced that Thomas J. Paulson, Chief Financial Officer of NovaBay Pharmaceuticals, will present a corporate and clinical update at the Southern California Investor Conference, held on August 8, 2013 in Newport Beach, CA. Mr. Paulson will be available to respond to questions and to participate in one-on-one meetings with investors attending the conference.

Event: Southern California Investor Conference
Date: Thursday, August 8, 2013
Time:  10:00 am PT
Place: Newport Beach, CA

To access the live audio webcast of this presentation, please log on through a link located in the News & Events section of NovaBay’s website at https://novabay.com/investors/events. A replay of the webcast will be available one hour after the conclusion of the live event.

About NovaBay Pharmaceuticals, Inc.
Going Beyond Antibiotics
NovaBay Pharmaceuticals is a biotechnology company focused on addressing the large unmet therapeutic needs of the global, topical anti-infective market with auriclosene. The Company’s four core business units – DermaBay, UroBay, EyeBay and MediBay – are developing products in dermatology, urology, ophthalmology, and wound care areas.

Stay informed on NovaBay’s progress:
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Join us on Google+
Visit NovaBay’s Website

NovaBay Pharmaceuticals Contacts
Thomas J. Paulson  
Chief Financial Officer
510-899-8809
Contact Thomas Paulson

Ana Kapor
Director, Investor Relations and Corporate Communications
NovaBay Pharmaceuticals, Inc.
510-899-8889
Contact Ana Kapor

 

 

TOP